New roles for Smad signaling and phosphatidic acid in the regulation of skeletal muscle mass
Open accessThe DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
Skeletal muscle is essential for normal bodily function and the loss of skeletal muscle (i.e. muscle atrophy/wasting) can have a major impact on mobility, whole-body metabolism, disease resistance, and quality of life. Thus, there is a clear need for the development of therapies that can prevent the loss, or increase, of skeletal muscle mass. However, in order to develop such therapies, we will first have to develop a thorough understanding of the molecular mechanisms that regulate muscle mass. Fortunately, our knowledge is rapidly advancing, and in this review, we will summarize recent studies that have expanded our understanding of the roles that Smad signaling and the synthesis of phosphatidic acid play in the regulation of skeletal muscle mass.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Assessing ribosome biogenesis in living human skeletal muscle presents profound methodological hurdles that frequently obscure the entire mechanistic continuum from mechanotransduction to phenotypic adaptation [20,23,30].”
From Ribosome Biogenesis as a Putative Bottleneck to Skeletal Muscle Hypertrophy: Mechanisms, Human Evidence, and Practical Modulators (2026) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lokireddy, S., McFarlane, C., Ge, X., Zhang, H., Sze, S. K., Sharma, M., & Kambadur, R. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1124 · Cited by 117 · cited 2×
“Furthermore, Smad3 has been found to be necessary for myostatin-induced increases in atrogin-1 expression and atrophy of cultured myotubes [40,41].”
RetractedFord, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012 · cited 1×
“The PLD1/PAinduced inhibition of these atrophy genes appears to be due to the activation of Akt, possibly via the activation of the rapamycin-insensitive mTOR complex 2 (mTORC2) [76-78].”
BackgroundStitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
Regulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616 · cited 1×
“Initial interest in the role of Smad signaling in the regulation of skeletal muscle mass largely stemmed from the discovery that the disruption of the GDF-8 (also known as the myostatin) gene, and the inhibition of myostatin receptor binding, produced marked skeletal muscle hypertrophy [30,31].”
BackgroundMechanisms regulating skeletal muscle growth and atrophy
Schiaffino, S., Dyar, K. A., Ciciliot, S., Blaauw, B., & Sandri, M. (2013) · The FEBS Journal · doi:10.1111/febs.12253 · Cited by 1,492 · cited 1×
“Importantly, it has been demonstrated that Smad3 signaling is necessary for the myostatin-induced inhibition of the Akt/mTORC1 pathway [40,50].”
BackgroundCellular and molecular mechanisms of muscle atrophy
Bonaldo, P., & Sandri, M. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.010389 · Cited by 1,284 · cited 1×
“injury-induced immobilization, severe burns, cancer cachexia, aging, heart failure, obesity, diabetes, chronic obstructive pulmonary disease, renal disease, and HIV) and can be induced by changes in a variety of factors, including nutrients, neural activity, cytokines, growth factors, hormones, and mechanical loading…”
BackgroundPhosphatidic Acid-Mediated Mitogenic Activation of mTOR Signaling
Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A., & Chen, J. (2001) · Science · doi:10.1126/science.1066015 · Cited by 1,055 · cited 3×
“…shown that the stimulation of cells with exogenous PA, or the overexpression of PA-generating enzymes, can activate mTORC1 signaling [62-66], whereas blocking the generation of PA has been reported to inhibit the activation of mTORC1 that occurs in response to various types of stimuli [60,67-70].”
Myostatin Inhibits Myoblast Differentiation by Down-regulating MyoD Expression
Langley, B., Thomas, M., Bishop, A., Sharma, M., Gilmour, S., & Kambadur, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204291200 · Cited by 908 · cited 1×
“Furthermore, it has since been shown that an increase in myostatin is often associated with skeletal muscle atrophy [32,33] and an increase in Smad3 phosphorylation [34].”
Background
Research works printed but not linked: 1
- [79]O'Neil TK Duffy LR Frey JW Hornberger TA The role of phosphoinositide 3-kinase and phosphatidic acid in the regulation of mammalian target of rapamycin following eccentric contractions J Physiol (Lond) 2009 587 3691 701 10.1113/jphysiol.2009.173609 19470781 PMC2742291 · DOI · Paper page
Cited by
Roberts, M. D., McCarthy, J. J., Hornberger, T. A., Phillips, S. M., Mackey, A. L., Nader, G. A., Boppart, M. D., Kavazis, A. N., Reidy, P. T., Ogasawara, R., et al. (2023) · Physiological Reviews · doi:10.1152/physrev.00039.2022 · Cited by 214
Self-citationDysregulation of skeletal muscle protein metabolism by alcohol
Steiner, J. L., & Lang, C. H. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00006.2015 · Cited by 151
“For instance, Smad signaling is required for the myostatin-mediated inhibition of Akt/ mTORC1 signaling and myotube atrophy, as well as for TGF -induced fiber atrophy (30, 128, 146).”
BackgroundAlcoholic Myopathy: Pathophysiologic Mechanisms and Clinical Implications
Simon, L., Jolley, S. E., & Molina, P. E. (2017) · Alcohol research · doi:10.35946/arcr.v38.2.05 · Cited by 119
“Smad signaling is required for myostatin-mediated inhibition of Akt/mTORC1 signaling, myotube atrophy, and TGF-β–induced fiber atrophy (Goodman and Hornberger 2014; McFarlane et al. 2006), all of which lead to a reduction of muscle Figure 1 Principal effects of chronic alcohol abuse on anabolic and catabolic mechanisms”
Androgen-mediated regulation of skeletal muscle protein balance
Rossetti, M. L., Steiner, J. L., & Gordon, B. S. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.031 · Cited by 95
Wen, Y., Dungan, C. M., Mobley, C. B., Valentino, T., von Walden, F., & Murach, K. A. (2021) · Function · doi:10.1093/function/zqab038 · Cited by 75
lncRNA Chronos is an aging-induced inhibitor of muscle hypertrophy
Neppl, R. L., Wu, C., & Walsh, K. X. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201612100 · Cited by 54
“, 2015), and in part, by inhibiting PI3K/Akt/mTOR signaling (Sartori et al., 2009; Goodman and Hornberger, 2014).”
BackgroundNetwork Modules Uncover Mechanisms of Skeletal Muscle Dysfunction in COPD Patients
Tényi, Á., Cano, I., Marabita, F., Kiani, N., Kalko, S. G., Barreiro, E., de Atauri, P., Cascante, M., Gomez-Cabrero, D., & Roca, J. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1405-y · Cited by 40
“Abnormal TGF-β signaling was suggested by up-regulation of its inhibitor SMURF1 and further strengthened by the observed down-regulation of SMURF1’s binding competitor (PDLIM7) [38] potentially leading to increased protein degradation by ubiquitination [39].”
BackgroundRimington, R. P., Capel, A. J., Chaplin, K. F., Fleming, J. W., Bandulasena, H., Bibb, R., Christie, S. D. R., & Lewis, M. P. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00975 · Cited by 24
Transcriptional programming of translation by BCL6 controls skeletal muscle proteostasis
Ramachandran, K., Futtner, C. R., Sommars, M. A., Quattrocelli, M., Omura, Y., Fruzyna, E., Wang, J. C., Waldeck, N. J., Senagolage, M. D., Telles, C. G., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-00983-3 · Cited by 20
“Conversely, bone morphogenetic proteins induce muscle hypertrophy by activating SMAD1/SMAD5/SMAD8 and mTOR signalling 7 .”
Transcriptional regulation of autophagy in skeletal muscle stem cells
Krishnan, P. D. G., Lee, W. X., Goh, K. Y., Choy, S. M., Turqueza, L. R. R., Lim, Z. H., & Tang, H.-W. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052007 · Cited by 23
“These phosphorylated SMADs then form complexes with SMAD4, translocating into the nucleus to modulate downstream gene expression (Goodman and Hornberger, 2014).”
Mechanotransduction for Muscle Protein Synthesis via Mechanically Activated Ion Channels
Mirzoev, T. M. (2023) · Life · doi:10.3390/life13020341 · Cited by 17
The Plateau in Muscle Growth with Resistance Training: An Exploration of Possible Mechanisms
Kataoka, R., Hammert, W. B., Yamada, Y., Song, J. S., Seffrin, A., Kang, A., Spitz, R. W., Wong, V. H. Y., & Loenneke, J. P. (2023) · Sports Medicine · doi:10.1007/s40279-023-01932-y · Cited by 18
“Myostatin, a member of the transforming growth factor-β superfamily, is recognized as a powerful negative regulator of skeletal muscle mass by inhibiting the Akt/mTORC1 signaling pathway [133, 134].”
Benyamini, H., Kling, Y., Yakovlev, L., Becker‐Cohen, M., Nevo, Y., Elgavish, S., Harazi, A., Argov, Z., Sela, I., & Mitrani‐Rosenbaum, S. (2020) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-190461 · Cited by 14
Local low‐intensity vibration improves healing of muscle injury in mice
Corbiere, T. F., & Koh, T. J. (2020) · Physiological Reports · doi:10.14814/phy2.14356 · Cited by 13
“The Akt/mTOR/p70S6K pathway can be activated by IGF-1 and although we did not find any effect of LIV on IGF-1 levels, this pathway can also influence muscle growth via IGF-1-independent mechanisms (Goodman & Hornberger, 2014; Spangenburg, Le Roith, Ward, & Bodine, 2008).”
BackgroundFowler, A., Knaus, K. R., Khuu, S., Khalilimeybodi, A., Schenk, S., Ward, S. R., Fry, A. C., Rangamani, P., & McCulloch, A. D. (2024) · Experimental Physiology · doi:10.1113/ep091712 · Cited by 13
MicroRNAs and their Modulatory Effect on the Hallmarks of Osteosarcopenia
Silva, W. J., Cruz, A., & Duque, G. (2024) · Current Osteoporosis Reports · doi:10.1007/s11914-024-00880-4 · Cited by 10
“Activation of this microRNA can inhibit the activity of SMAD1/4, resulting in the release of inhibition on HDAC4 [107, 108].”
Cano-Martínez, A., Méndez-Castro, J. A., García-Vázquez, V. E., Carreón‐Torres, E., Díaz‐Díaz, E., Sánchez-Aguilar, M., Castrejón-Téllez, V., & Rubio-Ruiz, M. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104952 · Cited by 10
“This Smad heteromultimer acts as an inducible transcription factor that regulates skeletal muscle mass and is involved in muscle atrophy [10,11,14].”
Santos, H. O., Cerqueira, H. S. C., & Tinsley, G. M. (2022) · Metabolites · doi:10.3390/metabo12111146 · Cited by 9
“Indeed, myostatin-mediated Smad signaling is a decisive pathway in declining myofibrillar protein synthesis while increasing protein degradation, such as Smads 2 and 3 inhibit the protein kinase B/mammalian target of rapamycin (Akt/mTOR) signaling and trigger the expression of ubiquitin proteasome E3 ligases, atrogin-…”
BackgroundThe quasi-parallel lives of satellite cells and atrophying muscle
Biressi, S., & Gopinath, S. D. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00140 · Cited by 11
Fat, muscle, and anti-obesity medications in cardiovascular disease prevention
Khan, M. S., Dawood, M. H., Handelsman, Y., Anker, S. D., Coats, A. J. S., Green, J. B., & Butler, J. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag201 · Cited by 9
mTORC1 and BMP-Smad1/5 regulation of serum-stimulated myotube hypertrophy: a role for autophagy
Zhang, Q., Halle, J. L., Counts, B. R., Pi, M., & Carson, J. A. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00237.2024 · Cited by 5
GDF10 exacerbates metastatic burden and cachexia in murine models of cancer
James, L. S., Saunders, A. A. E., Karagiannis, C., Qian, H., Anderson, R. L., Thomson, R. E., Goodman, C. A., & Gregorevic, P. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1773275 · Cited by 3
Self-citationSabbatini, D., Gorgoglione, D., Minervini, G., Fusto, A., Suman, M., Romualdi, C., Vianello, S., Capece, G., Sorarú, G., Marchioretti, C., et al. (2025) · Biomolecules · doi:10.3390/biom15111599 · Cited by 2
“A preliminary but interesting observation was the detection of dysregulated SMAD protein signalling [66,67].”
Yoshihara, T., Dobashi, S., Takaragawa, M., & Naıto, H. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175223 · Cited by 3
Physiological basis of the pathogenesis of alcohol-induced skeletal muscle injury
Zinovyeva, O. E., Emelyanova, A. Y., Samkhaeva, N. D., Щеглова, Н. С., Shenkman, E. A., & Nemirovskaya, T. L. (2016) · Human Physiology · doi:10.1134/s0362119716020171 · Cited by 2
Muñoz López, M., López-Gil, J. F., Ramírez de la piscina Viúdez, X., Baz-Valle, E., & Tornero Aguilera, J. F. (2026) · Cells · doi:10.3390/cells15111041 · Cited by 1
“Assessing ribosome biogenesis in living human skeletal muscle presents profound methodological hurdles that frequently obscure the entire mechanistic continuum from mechanotransduction to phenotypic adaptation [20,23,30].”
Willoughby, D. S. (2015) · International Journal of Food and Nutritional Science · doi:10.15436/2377-0619.15.011 · Cited by 2
“In accordance to the regulation of mTORC1 signaling, it has been shown that the over expression of PLD1 was associated with an increase in mTORC1 activity[42].”
BackgroundCritical illness myopathy : effects of specific intervention strategies and molecular mechanisms
Corpeño, R. (2015) · Figshare
Simvastatin Induces Avian Muscle Protein Degradation through Muscle Atrophy Signaling
Park, J.-W., Choi, Y.-S., Choi, S., Lee, S. I., & Shin, S. (2022) · Korean Journal of Poultry Science · doi:10.5536/kjps.2022.49.4.265
The Impact of Alcohol on Muscle Protein Synthesis: Molecular Aspects
Mirzoev, T. M. (2026) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093026030129
“Pro(cid:2) teins of the Smad family are involved in signal transduction from TGF-β receptors and are known to mediate decreased AKT/mTORC1 signaling activity and induce atrophic changes in skeletal mus(cid:2) cles [61, 62].”
Metadata
- Authors
- Goodman, C. A., & Hornberger, T. A.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Hornberger, Troy A.
- Venue
- F1000Prime Reports
- Publisher
- Faculty Opinions Ltd
- Published
- 2014-04-01
- Volume
- 6
- Pages
- 20-20
- ISSN
- 2051-7599 (ISSN-L)
- PMC
- PMC3974568
- OpenAlex
- W2095126612
- Cited by
- 30
- References
- 85
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 3 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 4
- FWCI
- 0.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- F1000Prime Reports (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Victoria University Research Repository (Victoria University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (AR057347)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R21AR063256, R01AR057347)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- Smad signaling, phosphatidic acid, skeletal muscle mass, muscle atrophy, muscle mass regulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.